cobalt has been researched along with Ureteral Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, X; Hu, J; Lai, X; Tan, L; Wang, S | 1 |
| Hu, J; Li, A; Li, M; Tan, L; Tang, L | 1 |
2 other study(ies) available for cobalt and Ureteral Obstruction
| Article | Year |
|---|---|
A pH-Responsive System Based on Fluorescence Enhanced Gold Nanoparticles for Renal Targeting Drug Delivery and Fibrosis Therapy.
Topics: Animals; Cell Line; Cobalt; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fibrosis; Fluorescence; Glutathione; Gold; Hydrogen-Ion Concentration; Kidney; Kidney Diseases; Metal Nanoparticles; Mice, Inbred BALB C; Mononuclear Phagocyte System; Rats; Ureteral Obstruction | 2020 |
Hydrosoluble 50% N-acetylation-thiolated chitosan complex with cobalt as a pH-responsive renal fibrosis targeting drugs.
Topics: Acetylation; Animals; Biocompatible Materials; Cell Line; Chitosan; Cobalt; Drug Delivery Systems; Drug Liberation; Fibrosis; Humans; Hydrogen-Ion Concentration; Kidney; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Nanoparticles; Rats; Solubility; Sulfhydryl Compounds; Ureteral Obstruction | 2016 |